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Background: Nasopharyngeal carcinoma (NPC) is a common malignant tumor observed in the populations of
southern China and Southeast Asia. However, little is known about the effects of purinergic signal on the behavior
of NPC cells. This study analyzed the effects of ATP on the growth and migration of NPC cells, and further
investigated the potential mechanisms during the effects.
Methods: Cell viability was estimated by MTT assay. Transwell assay was utilized to assess the motility of NPC cells.
Cell cycle and apoptosis were detected by flow cytometry analysis. Changes in OPN, P2Y2 and p65 expression were
assessed by western blotting analysis or immunofluorescence. The effects of ATP and P2Y2 on promoter activity of
OPN were analyzed by luciferase activity assay. The binding of p65 to the promoter region of OPN was examined
by ChIP assay.
Results: An MTT assay indicated that ATP inhibited the proliferation of NPC cells in time- and dose-dependent
manners, and a Transwell assay showed that extracellular ATP inhibited the motility of NPC cells. We further
investigated the potential mechanisms involved in the inhibitory effect of extracellular ATP on the growth of NPC
cells and found that extracellular ATP could reduce Bcl-2 and p-AKT levels while elevating Bax and cleaved
caspase-3 levels in NPC cells. Decreased levels of p65 and osteopontin were also detected in the ATP-treated NPC
cells. We demonstrated that extracellular ATP inhibited the growth of NPC cells via p65 and osteopontin and
verified that P2Y2 overexpression elevated the inhibitory effect of extracellular ATP on the proliferation of NPC cells.
Moreover, a dual luciferase reporter assay showed that the level of osteopontin transcription was inhibited by
extracellular ATP and P2Y2. ATP decreased the binding of p65 to potential sites in the OPN promoter region in
NPC cells.
Conclusion: This study indicated that extracellular ATP inhibited the growth of NPC cells via P2Y2, p65 and OPN.
ATP could be a promising agent serving as an adjuvant in the treatment of NPC.
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Accumulating evidence has associated purinergic sig-
nals, which are induced by extracellular nucleotides, to
the processes of several diseases [1]. Extracellular nucleo-
tides, particularly ATP, are important transmitters that
mediate various biological effects via purinergic receptors
(P2-receptors) in many cell types [2], and several studies
have found that ATP can inhibit tumor growth [3-6].
P2 receptors are subclassified into two main types: P2X
and P2Y receptors [7]. P2X receptors are ligand-gated
ion channels that are activated by extracellular ATP to
elicit a flow of cations [2], seven of which, P2X1 to P2X7,
have been cloned [8]. The metabotropic P2Y receptors
belonging to the G-protein-coupled receptor (GPCR)
family play important roles in several signaling pathways,
and eight P2Y receptors have been cloned and identified
as GPCRs in mammals [2,9]. Although P2Y receptors are
distributed in a wide range of normal tissues, P2X recep-
tors are mainly expressed in the nervous system, platelets,
and smooth muscle cells (SMCs) [10,11]. P2Y2 has often
been reported to be a functional receptor that transduces
several biological signals induced by ATP and UTP, stud-
ies largely conducted in normal cells, such as epithelial
cells, smooth muscle cells, leukocytes, and nerve cells. It
has also been reported that P2Y2 activates nerve growth
factor signaling to enhance neuronal differentiation and
is also involved in phagocytic clearance [12-15]. How-
ever, the role of P2Y2 in tumor cells remains poorly
understood, though some reports have described the pos-
sible role of P2Y2 in effects of extracellular nucleotides on
tumor cells [4]. Osteopontin (OPN) is a secreted arginine-
glycine-aspartic acid (RGD)-containing phosphoprotein
with a thrombin cleavage site. By binding to several integ-
rins and CD44 variants, OPN plays an important role in
tumorigenesis, tumor invasion, tumor growth, and metas-
tasis in many types of cancers [16-18]. OPN has been
shown to promote cell survival through the inhibition of
apoptosis, and OPN downregulation decreases the motil-
ity and invasiveness of tumor cells [19,20]. Although it has
been reported that extracellular nucleotides induce OPN
expression in arterial SMCs [21], their effect on OPN ex-
pression in tumor cells has not been examined.
Purinergic signaling has thus far not been investigated
in NPC cells, and the effect of extracellular ATP on
tumor cell OPN levels is unclear. Therefore, the effects
of ATP on NPC cell apoptosis, cell cycle arrest, and cell
migration were investigated in the present study, and we




ATP was purchased from Amersco (Solon, Ohio, USA),
prepared in water, and stored in aliquots of an appropriatevolume at −20°C until use. The antibodies used were
anti-OPN (Sigma, USA), anti-P2Y2 (Santa Cruz, USA),
and anti-cleaved caspase-3 (Cell Signal Technology,
USA); other antibodies were purchased from Beyotime
(Nantong, China).
Cell culture and transfection
The cell lines 5-8 F and CNE-2 were gifts from Dr. Shan
Jiang, State Key Laboratory of Oncology in Southern
China, SunYat-Sen University, Guangzhou, P. R. China.
The cells were cultured in DMEM supplemented with
heat-inactivated fetal calf serum and penicillin (100 U/ml)/
streptomycin (100 mg/mL) in 5% CO2 at 37°C. The
transfection of plasmids and siRNA was performed using
Lipofectamine 2000 (Invitrogen, USA) according to the
manufacturer’s instructions.
MTT assay
The cell lines were seeded in 96-well plates at a density
of 5000 cells per well in a volume of 150 μL of culture
medium per well. After 24 h, ATP was added to the
wells at different concentrations in triplicate. The plates
were incubated at 37°C in 5% CO2 for 24 or 48 h. If a
transfection was performed, ATP was added to the wells
after the transfection for 24 h. A 20-μL sample of MTT
solution (5 g/L, dissolved in PBS) was added to each
well, and the plates were incubated at 37°C for an add-
itional 4 h. The supernatant was discarded, and l50 μL
of DMSO was added to dissolve the formazan product.
The absorbance values at 570 nm (A570) were deter-
mined using a multi-well plate reader (Tecan, Maennedorf,
Switzerland).
Measurement of intracellular calcium
The change of intracellular Ca2+ concentration in the cul-
tured 5-8 F and CNE2 cells was measured using the
fluorescence probe fluo-3 with acetoxymethyl ester. The
two cell lines were grown in 96-well plates (black well,
clear bottom; Greiner Bio One) until confluence. The
dyes were loaded into the cells by adding 5 μM fluo-
3 AM from 1 mM stock in DMSO to a bath solution
containing the following: 20 mM HEPES, 140 mM NaCl,
5 mM KCl, 1 mM CaCl2, 1 mM, K2HPO4, 1 mM MgCl2
and 5 mM glucose with the pH adjusted to 7.4. The cells
were incubated for 40 min at 37°C in the dark. After
loading, the cells were subsequently washed three times
in bathing solution, and then, 100 μl of bathing solution
was added to each well. The plates were then placed in a
multifunctional multi-well plate reader (Genios Plus,
Tecan). The fluorescence density was measured after the
addition of 100 μl of control buffer or 100 μl of the indi-
cated concentration of ATP in bath solution with or
without receptor antagonists (PPADS, suramin). The
absorption wavelength was 535 nm, and the excitation
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lular Ca2+ was also observed under inverted fluorescence
microscopy.
siRNA sequences and plasmid construction
The coding sequences of P2Y2 and OPN were amplified
from CNE-2 cells, and each was cloned into pcDNA3.1.
The siRNA used for human OPN knockdown was a mix-
ture of 5′-GUGGGAAGGACAGUUAUGATT-3′ and 5′-
GUCUCACCAUUCUGAUGAATT-3′. The siRNA con-
trol sequence was 5′-ACGCATGCATGCTTGCTTT-3′.
The plasmid used for p65 knockdown was a gift from
Dr Yang Zhang (Department of Biochemistry and Molecu-
lar Biology, Zhongshan School of Medicine, Sun Yat-Sen
University, China) and was based on pSilence2.0-U6, with
the following sequence: 5′-CGCTGCAGTTTGATGAT
GAATTCAAGAGATTCATCATCAAACTGCAGCTTT
TTTG-3′. P2Y2-shRNA expression plasmids were con-
structed based on plasmid pcDNA3.1(+) (Invitrogen, USA)
according to a previous report [22]. EGFP was amplified
by PCR from pEGFP-N1 (Clontech, USA), and the human
U6 promoter was obtained from the human genome. The
EGFP fragment was inserted between the KpnI and Bam
HI sites of pcDNA3.1(+), and the U6 promoter was
inserted into the Bam HI and Eco RI sites of pcDNA3.1(+).
The siRNA sequence targeting the human P2Y2 transcript








A cell cycle analysis was performed by flow cytometry.
DNA labeling was performed using the Cycletest Plus
DNA Reagent kit (BD Biosciences Pharmingen, USA),
and the samples were analyzed using a flow cytometer
(Beckman Counter, USA). For the detection of apoptotic
cells, labeling tests involving both propidium iodide
(PI) and annexin-V were performed using an annexin-V
staining kit (Invitrogen, USA) according to the manufac-
turer’s instructions.
Transwell assay
Cell migration assays were performed using the Transwell
(Costar, USA) system, which allows cells to migrate through
8-μm pore polycarbonate membranes. ATP (100 μM) was
included or omitted in the medium in both the upper and
lower compartments of the chambers. The chambers were
incubated for 24 h at 37°C in humidified 5% CO2 air. The
membranes were then washed with PBS, and the cells werefixed with cold methanol for 15 min and stained with crys-
tal violet. The cells beneath the membrane were counted in
5 high-power microscopic fields. Each experiment was per-
formed using three Transwell chambers and repeated three
times.
Immunofluorescence
Cells were treated with ATP for 36 h, washed with PBS,
and fixed for 20 min at room temperature with 4% para-
formaldehyde. The cells were washed again with PBS
and permeabilized with Triton X-100 for 10 min at room
temperature; the cells were then washed with PBS, incu-
bated with 3% BSA to block non-specific binding sites,
and incubated with primary antibodies at 4°C for 15 h.
The cells were washed three times with PBS, incubated
with the secondary antibody for 1 h at room temperature,
and observed using an inverted fluorescence microscope
after washing three times with PBS.
Western blot analysis
Cells were exposed to various experimental conditions
for the indicated times before being harvested and lysed
for protein extraction. The protein concentration was de-
termined using the Bio-Rad protein assay kit (Bio-Rad,
P. R. China). The blots were visualized using an enhanced
chemiluminescence detection system (Amersham, Pittsburgh,
USA). β-actin was used as a loading control.
Luciferase reporter assay
5-8 F and CNE-2 cells were seeded at 5 × 103 per well
in 96-well plates the day before transfection. A 683-bp
promoter region (−365 to +318) of OPN was inserted
into the pGL3-Basic luciferase reporter vector (Promega,
USA). The cells were co-transfected with 0.1 μg of fire-
fly luciferase reporter construct, 0.01 μg of pRL-TK
Renilla luciferase reporter plasmid (Promega, USA),
and the pcDNA3.1-P2Y2 vector using Lipofectamine
2000 (Invitrogen, USA). The luciferase activity was ex-
amined using a dual-luciferase reporter assay system
(Promega, USA) according to the manufacturer’s instruc-
tions, and the signal was normalized to the internal Renilla
control for the transfection efficiency.
Chromatin immunoprecipitation
5-8 F and CNE-2 cells treated with or without ATP were
utilized for chromatin immunoprecipitation using the
EZ ChIP kit (Millipore, USA) according to the manu-
facturer’s instructions. After elution and purification,
the recovered immunoprecipitated DNA samples were
used for PCR with primers 5′-CAGTTGCAGCCTTC
TCAGC-3′ (forward) and 5′-CCTTTGTTCCACAGG
AGACC-3′ (reverse) to amplify a 201-bp segment of the
OPN promoter containing the potential p65 binding
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electrophoresis.
Statistical analysis
A statistical analysis was performed using the unpaired
Student’s t-test. P values < 0.05 were considered statisti-
cally significant.
Results
Effects of extracellular ATP on the proliferation and
migration of NPC cell lines
The viability of the two cell lines was measured by an
MTT assay after treatment with ATP for 24, 48, and
72 h. The growth of 5-8 F and CNE-2 cells was inhibited
by treatment with ATP (20 μM, 50 μM, or 100 μM) in a
dose- and time-dependent manner, with a striking effect
after 48 h of treatment (Figure 1A). The effect of ATP
(10 μM) on the migration of cultured 5-8 F and CNE-2
cells was measured using the Transwell system byFigure 1 Effects of ATP on the growth and migration of nasopharyng
effects of ATP on 5-8 F and CNE-2 cell growth after incubation with ATP. T
performed in quadruplicate. Statistical significance between the control an
48 h and 72 h; P < 0.01 for other time points. B: ATP inhibited the migratio
incubation with ATP (10 μM) for 24 h. The data represent means ± SD of re
between the control and treated conditions: *P < 0.05.counting the cells that migrated below the membrane
(Figure 1B). We found the notable inhibition by ATP
on the motility of the two NPC cell lines: after treat-
ment with 10 μM ATP for 24 h, the motility of the 5-8 F
and CNE-2 cells was 23.3% and 27.1% lower than the
control groups.
ATP induces apoptosis and S-phase arrest in NPC cells
A flow cytometry analysis with propidium iodide (PI) and
annexin V staining was performed to confirm apoptosis.
As shown in Figure 2A, there was a significant increase in
apoptotic cells after 48 h of incubation. Treatment with
100 μM ATP resulted in increased levels of annexin V-
positive and PI-positive cell fractions of 5-8 F and CNE-2
cells (5.8% versus 27.4%; 2.5% versus 23.4%), indicating
that ATP induced apoptosis in NPC cells. The cell cycle
was analyzed to assess whether the growth inhibitory ef-
fect of extracellular ATP on NPC cells was mediated by
cell cycle arrest. As shown in Figure 2B, incubating witheal carcinoma cell lines. A: Dose-dependent and time-dependent
he data represent the means ± SD of 3 independent experiments
d treated conditions: P < 0.05 for 50–100 μM of 24 h and 20 μM of
n of 5-8 F and CNE-2 cells. NPC cell migration was evaluated after
lative migration vs. control from 3 experiments. Statistical significance
Figure 2 (See legend on next page.)
Yang et al. Journal of Experimental & Clinical Cancer Research 2014, 33:53 Page 5 of 14
http://www.jeccr.com/content/33/1/53
(See figure on previous page.)
Figure 2 Flow cytometry analysis of apoptosis and the cell cycle. A: ATP induced apoptosis in NPC cells. 5-8 F and CNE-2 cells were treated
with ATP for 48 h at a concentration of 100 μM; a flow cytometry analysis (staining with propidium iodide and annexin V-FITC) for cell death was
performed. The lower left section of each graph represents the viable cells, the lower right section represents the apoptotic cells, and the upper
right section represents the necrotic and late apoptotic cells. The total percentage of the counts in the lower right and upper right sections was
calculated. B: ATP induced S phase arrest in NPC cells. 5-8 F and CNE-2 cells were treated with ATP for 24 h at a concentration of 100 μM, and
the cells were subjected to a flow cytometry analysis. ATP showed a significant influence on the distribution of the cell cycle in 5-8 F and CNE-2
cells. C: The level of Bax was elevated, whereas Bcl-2 decreased in the ATP-treated NPC cells; the cleaved band of caspase-3 indicated that
apoptosis had occurred in the ATP-treated NPC cells. Statistical significance between the control and treated conditions: *P < 0.05,
**P < 0.01 and ***P < 0.001.
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proportion of 5-8 F and CNE-2 cells in S phase (23.9%
versus 37.3%; 28.9% versus 41.2%). The levels of proteins
associated cell apoptosis, such as Bax, Bcl-2, and cleaved
caspase-3, were also detected after treated with 100 μM
ATP for the indicated time. As shown in Figure 2C, the
level of Bcl-2 decreased, whereas Bax increased; an obvi-
ous cleaved caspase-3 band was also observed in the NPC
cell lines.
Intracellular calcium levels are changed in response to
ATP
The addition of ATP increased the calcium concentration
in 5-8 F and CNE-2 cells in a dose-dependent manner. An
initial transient [Ca2+]i peak was followed by a secondary
reduced phase. The biphasic response to stimulation with
ATP implies the existence of metabotropic P2Y-receptors.
The first response suggested the mobilization of Ca2+
from intracellular stores. The second peak is due to the
calcium-mediated calcium influx across the cell mem-
brane (Figure 3A). Additionally, we observed changes in
fluorescence of intracellular Ca2+ under inverted fluores-
cence microscopy (Figure 3B). The rise in intracellular cal-
cium is reduced when the cells were incubated with
PPADS or suramin (50 μM) for 30 min prior to treatment
with ATP (Figure 3C).
Effects of extracellular ATP on the levels of p65 and OPN
in NPC cells
We detected the expression of p65 and OPN in NPC
cells using immunofluorescence and western blotting as-
says. NPC cells were treated with ATP (100 μM) for the
indicated time, and the cells were then subjected to im-
munofluorescence and western blotting, as shown in
Figure 4A. ATP was found to significantly decrease the
expression of cytosolic and nuclear p65 in both the 5-8 F
and CNE-2 cells, similar to the situation for p65, and ATP
also decreased the expression of OPN in the two NPC cell
lines (Figure 4B).
Vector-based RNAi decreases P2Y2 expression
As there is scant literature describing vector-based RNAi
of P2Y2 expression, we selected an effective vector todownregulate the level of P2Y2. Western blotting
(Figure 5B) revealed that the CNE-2 cells transfected
with P2Y2 shRNA exhibited a much weaker band com-
pared to the control group. This result indicated that the
constructed P2Y2 shRNA-expressing vector could effect-
ively downregulate the protein level of P2Y2. In contrast,
pcDNA3.1-P2Y2 upregulated the protein level of P2Y2 in
CNE-2 cells.Effects of P2Y2 and OPN on CNE-2 cell chemosensitivity
to ATP
To examine the role of P2Y2 and OPN in the effect of
ATP on the proliferation of CNE-2 cells, the cells were
transfected with constructed plasmids or siRNA for 24 h
and then cultured with ATP (100 μM) for another 48 h.
An MTT assay was used to evaluate cell viability after
treatment with ATP. As shown in Figure 5B, we found
that OPN downregulation increased the sensitivity of
CNE-2 cells to ATP, whereas OPN overexpression resulted
in a higher cell viability compared to the corresponding
control group. OPN overexpression itself showed no
obvious effect on the viability of CNE-2 cells [23]. We
further found that the upregulation of P2Y2 could de-
crease CNE-2 cell viability, with P2Y2 downregulation
having no obvious influence on CNE-2 cell viability. These
results indicated that P2Y2 and OPN participate in the ef-
fect of ATP on the proliferation of CNE-2 cells.Effects of P2Y2 expression on CNE-2 cell cycle and
apoptosis
The cell cycle distribution was analyzed by flow cytome-
try after the cells were transfected with the P2Y2 expres-
sion vector for 24 h and treated with 100 μM ATP for
another 48 h. As shown in Figure 5C, the proportion of
pcDNA3.1-P2Y2-transfected cells in G2/M phase de-
creased (9.3% to 6.8%), whereas those in G1 phase in-
creased (54.7% to 60%) compared to the control group.
To assess apoptosis, cells were transfected with the P2Y2
expression vector for 24 h and were then treated with
100 μM ATP for another 48 h before analysis by flow
cytometry. The results indicated that overexpression of
P2Y2 increased the apoptosis of CNE-2 cells (Figure 5C).
Figure 3 The response of intracellular Ca2+ levels after ATP stimulation with or without receptor antagonists (PPADS, suramin).
A: The representative response curves of intracellular calcium level after ATP treatment. B: The representative fluorescence changes of
intracellular Ca2+ obtained under inverted fluorescence microscopy. C: ATP induced a response of intracellular calcium level in dose
dependent manner, and the receptor antagonists (PPADS, suramin) reduced the response after ATP treatment.
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cells
As P2Y2 might be involved in the ATP-induced down-
regulation of p65 and OPN, we further examined the ef-
fect of P2Y2 on the level of p65 and OPN by western
blotting. As shown in Figure 6A, after 5-8 F and CNE-2
cell transfection of the constructed plasmids for 72 h,
the levels of p65 and OPN were decreased in the P2Y2-
overexpression group. It has been reported that p65 can
upregulate the expression of OPN in some tumor cells
[24], and we confirmed the potential regulation of OPN
by p65 and the effects of ATP on the transcriptional
activity of p65 toward OPN in 5-8 F and CNE-2 cells.
We found that OPN decreased when the 5-8 F and
CNE-2 cells were transfected with the p65 shRNA-
expressing vector, and a luciferase activity assay indi-
cated that ATP and its P2Y2 receptor could decreasethe transcriptional activity of OPN promoter in 5-8 F and
CNE-2 cells (Figure 6B). Using a ChIP assay, we further
found that ATP could lower the binding of p65 to poten-
tial sites in the OPN promoter region (Figure 6C). Ac-
cordingly, ATP might exert its inhibitory effects in NPC
cells, at least in part, via P2Y2, p65, and OPN.
P-AKT is involved with OPN in the chemosensitivity of
CNE-2 cells to ATP
It has been reported OPN can influence the level of
p-AKT in some tumor cells, and vice versa [24-26]; how-
ever, the situation in NPC cells is still unknown. We de-
tected the relationship between p-AKT and OPN on the
effects of ATP after CNE-2 cell transfection with OPN the
siRNA or OPN expression vector. The cells were further
incubated with ATP (100 μM) for 48 h after 24 h of trans-
fection, and western blotting assays were performed. As
Figure 4 The effects of extracellular ATP on the expression of p65 and OPN in NPC cells. A: 5-8 F or CNE-2 cells were incubated with ATP
(100 μM), and western blotting and immunofluorescence were used to detect the expression of p65. A notable decrease in p65 in the nucleus of
5-8 F and CNE-2 cells treated with ATP was found. The intensity of the bands was quantified. B: 5-8 F or CNE-2 cells were incubated with ATP
(100 μM) for the indicated time, and OPN expression was detected by western blotting, with quantification of the band intensity. Similar to the
situation for p65 in NPC cells, ATP significantly downregulated OPN expression in 5-8 F and CNE-2 cells. Statistical significance between the
control and treated conditions: *P < 0.05.
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Figure 5 The role of P2Y2 in mediating the effects of ATP on NPC cells. A: Schematic representation of the constructed vectors. CMV, CMV
promoter; EGFP, enhanced green fluorescent protein gene; U6, U6 promoter. B: P2Y2 and OPN regulate the growth inhibitory effects of
ATP on NPC cells. The levels of P2Y2 and OPN were significantly decreased after transfection with the shRNA expressing vector or siRNA.
P2Y2 overexpression enhanced the growth inhibitory effect of ATP on NPC cells, whereas OPN overexpression reversed this effect. There were
statistically significant differences between the control and treated conditions: *P < 0.05. C: The role of P2Y2 expression in the effects of ATP on the cell
cycle and apoptosis of CNE-2 cells. P2Y2 expression increased the percentage of G1-phase cells and decreased the proportion of G2/M-phase cells.
The overexpression of P2Y2 increased the level of apoptotic cells in ATP treated cells.
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Figure 6 Effects of ATP and P2Y2 on the regulation of OPN by p65. A: Overexpression of P2Y2 downregulated the levels of p65 and OPN,
and p65 knockdown with shRNA decreased the level of OPN in 5-8 F and CNE-2 cells. B: ATP and P2Y2 reduced the transcriptional activity of
OPN promoter. C: ATP lowered the binding of p65 to the promoter region of OPN in 5-8 F and CNE-2 cells. The data represent the means ± SD
of 3 independent experiments. Statistical significance between the control and treated conditions: *P < 0.05 (100 μM).
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level of p-AKT (both Thr308 and Ser473), whereas OPN
upregulation had the opposite effect of increasing p-AKT
(both Thr308 and Ser473). ATP alone also decreased the
level of p-AKT in a dose-dependent manner, which was
facilitated by OPN downregulation. We also verified that
P2Y2 overexpression further increased the effect of ATP
on the level of p-AKT in CNE-2 cells (Figure 7B).
Discussion
Our results show that extracellular ATP decreased the
viability and inhibited the migration of 5-8 F and CNE-2
cells. Notably, ATP-induced cell cycle arrest in S phase
was significant in these NPC cells. Given that certain che-
motherapeutic drugs are more cytotoxic to cells arrested
in S phase [27,28], the recruitment of cancer cells to S
phase by ATP might sensitize poorly differentiated NPC
cells to these drugs. Apoptosis was also induced in the
NPC cells treated with ATP. P2 receptors might be in-
volved in these effects. Because P2Y2 receptor is the main
subtype for ATP, P2Y2 might participate in the effects of
ATP on NPC cells. In the present study, P2Y2 promoted
the growth inhibition effects of ATP on NPC cells, similar
to the situation in some other tumor cells [4]. However,
some reports have shown that ATP can stimulate the
proliferation of cancer cells [29,30], though the under-
lying mechanism is unclear. For the first time in NPC
cells, our study showed that extracellular ATP inhibits
the proliferation and migration of NPC cells via the
downregulation of p65 and OPN. A recent report
provided evidence that ATP could inhibit the migra-
tion of NPC cells (CNE2Z) through the blockage of
volume-activated chloride channels [31], which is op-
posite to the situation in SMCs [21]. OPN, which was
detected in both 5-8 F and CNE-2 cells by western
blotting, has been studied extensively in several tumor
models and was found to be involved in the regula-
tion of several signal transduction pathways and fac-
tors, including the AKT pathway [24-26,32]. One recent
report also provided evidence that OPN could regulate
the growth of NPC cells [23]. Here, we report for the first
time that both OPN and ATP can affect the level of
p-AKT in NPC cells, and our results also indicate that
the AKT pathway might be involved in the effects of
ATP and OPN on NPC cells. As the inhibition of OPN
expression can result in a decrease in the metastatic po-
tential of tumor cells, these findings may therefore be ofgreat benefit for patient prognosis. Indeed, a higher level
of OPN was detected in the serum of NPC patients, and a
higher level of OPN was shown to decrease the sensitivity
of NPC cells to radiotherapy [33,34]. Given that radiother-
apy is the main therapy for NPC, the downregulation of
OPN by ATP might sensitize poorly differentiated NPC
cells to radiotherapy and decrease the metastatic potential
of these cells. Clearly, the effect of ATP on OPN expres-
sion in other tumor cells needs to be studied further.
Similar to many other purinergic receptors, the func-
tion of P2Y2 in tumor cells remains poorly understood.
Some reports have proposed a possible function of P2Y2
in tumor cells via changes in ion flux, and new func-
tional purinergic receptors are constantly being reported.
In our study, we constructed plasmids to specifically
regulate the P2Y2 level and then investigated its poten-
tial function. We showed that P2Y2 is involved in the ef-
fect of ATP on NPC cells via p65 and OPN and verified
that it exhibited growth inhibitory effects on tumor cells
on its own, results that are apparently contradictory to
the reports suggesting that P2Y2 is involved in the pro-
motion of proliferation [29,30]. ATP and its receptor
P2Y2 might exert opposite effects on migration in differ-
ent cell types: ATP and P2Y2 were found to stimulate
the migration of corneal epithelial cells but inhibit hu-
man keratinocyte spread and migration [35,36]. In the
present study, ATP exerted an inhibitory effect on NPC
cell motility, whereas P2Y2 itself showed no influence
on motility. We also used RT-PCR was used to detect
the expression of purinergic receptors in NPC cells, and
future studies will be aimed at investigating the function
of these receptors in tumor cells. The expression of
P2Y2 receptors in 5-8 F and CNE-2 cells was also exam-
ined by immunofluorescence microscopy.
It is well known that p65 signaling has important roles
in carcinogenesis, cancer development and progression
[37]. In addition, p65 signaling was involved in the ef-
fects of chemotherapeutic agents [38], and it might be
the attractive targets for the development of new anti-
cancer drugs [39]. The relationship between puriner-
gic signaling and p65 signaling in cancer cells is still
unclear. One recent report indicated that ATP could
inhibit the proliferation of endothelial progenitor cells
via inhibiting TLR4 activation induced phosphoryl-
ation of p65 [40]. In this study, we provided prelimin-
ary data about the effects of ATP and P2Y2 on p65
signaling in NPC cells.
Figure 7 P-AKT was involved in the effects of ATP and P2Y2 in NPC cells. A: The Akt pathway was involved in the effect of ATP on NPC
cells. ATP decreased the level of p-Akt in CNE-2 cells, and OPN downregulation decreased the level of p-Akt and enhanced the extent of the
downregulation of p-Akt by ATP. The overexpression of OPN increased the level of p-Akt and mitigated the effect of ATP on the p-Akt
level. B: The overexpression of P2Y2 could decrease the p-AKT level in CNE-2 cells. The level of p-Akt was detected by western blotting,
with quantification of the band intensity. Statistical significance between the control and treated conditions: *P < 0.05.
Yang et al. Journal of Experimental & Clinical Cancer Research 2014, 33:53 Page 12 of 14
http://www.jeccr.com/content/33/1/53
Yang et al. Journal of Experimental & Clinical Cancer Research 2014, 33:53 Page 13 of 14
http://www.jeccr.com/content/33/1/53In conclusion, the present results show that extra-
cellular ATP inhibits the growth and migration of NPC
cell lines, and some of these effects are mediated by the
downregulation of p65 and OPN via P2Y2. Therefore,
ATP could be a promising agent serving as an adjuvant in
the treatment of NPC. P2Y2 and OPN might be potential
targets of gene therapy, though further research in NPC
cells is needed.
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